Merck
MRK
2,299 hedge funds and large institutions have $163B invested in Merck in 2019 Q2 according to their latest regulatory filings, with 122 funds opening new positions, 957 increasing their positions, 938 reducing their positions, and 86 closing their positions.
42% more first-time investments, than exits
New positions opened: 122 | Existing positions closed: 86
2% more repeat investments, than reductions
Existing positions increased: 957 | Existing positions reduced: 938
0% more funds holding
Funds holding: 2,293 → 2,299 (+6)
0.3% less ownership
Funds ownership: 79.96% → 79.66% (-0.3%)
0% less capital invested
Capital invested by funds: $164B → $163B (-$668M)
11% less call options, than puts
Call options by funds: $1.25B | Put options by funds: $1.4B
11% less funds holding in top 10
Funds holding in top 10: 223 → 199 (-24)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
N
Nuveen
Charlotte,
North Carolina
|
+$1.92B |
| 2 |
KBG
Kahn Brothers Group
New York
|
+$790M |
| 3 |
BlackRock
New York
|
+$353M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$320M |
| 5 |
Korea Investment Corp
Seoul,
South Korea
|
+$263M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$913M |
| 2 |
Jennison Associates
New York
|
-$883M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$657M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$608M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$510M |
MRK Hedge Fund Activity: Q2 2019 in Review
2,299 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q2 2019, worth a combined $163B — down 0.41% from $164B a quarter earlier.
Buyers outnumbered sellers: 122 funds opened new MRK positions and 86 closed out — a net gain of 36 holders — while 957 added to existing stakes and 938 trimmed.
The largest buyer was Nuveen, adding an estimated $1.92B. The largest seller was JP Morgan Chase, cutting an estimated $913M.
- 2,299 institutional investors held Merck (MRK) as of Q2 2019, up from 2,293 in Q1 2019.
- Funds reported $163B of Merck stock for Q2 2019, down 0.41% quarter-over-quarter.
- 122 funds opened new Merck positions in Q2 2019 and 86 closed out, a net change of +36 holders.
- The largest Merck buyer in Q2 2019 was Nuveen, an estimated $1.92B added.
- The largest Merck seller in Q2 2019 was JP Morgan Chase, an estimated $913M sold.
Based on aggregated 13F filings for Q2 2019.